Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.44 USD | -4.17% | +0.47% | -23.61% |
May. 16 | Replimune Group, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
Apr. 08 | Replimune Group Provides Interim Results for Skin Cancer Therapy | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
REPLIMUNE GROUP, INC. | Other Biotechnology & Medical Research | -4.17% | +0.47% | -23.61% | -66.97% | -56.37% | 413M |
- Stock Market
- Equities
- REPL Stock
- Charts Replimune Group, Inc.
- Relative Strength Chart